GHK-Cu Topical Formulations Compared: Serum, Cream, and Solution — What Changes the Read
GHK-Cu is one of the few peptides that ends up in a wide range of cosmetic formats before most users have ever seen it as a research compound. The same copper-tripeptide complex gets sold as a thin water serum, as a rich cream with a half-dozen co-actives, as a plain aqueous solution intended for use after microneedling, and increasingly as a copper-loaded mask film. The labels rarely make the differences explicit, and the user-facing reviews tend to attribute every variation in result to "the GHK." A surprising amount of what people read as the molecule is actually the vehicle. The formulation is doing real work, and once it is separated from the active, the protocols stop contradicting each other.
What the molecule actually is
GHK-Cu is the tripeptide glycyl-L-histidyl-L-lysine bound to a copper(II) ion. The complex is what carries the biological activity associated with the molecule — modulation of dermal fibroblast behaviour, copper delivery to enzymatic sites, signalling effects on extracellular matrix turnover. The peptide alone, without copper, is a weaker actor; the copper alone, without the peptide, is a poor delivery vehicle and an irritant at the doses usually discussed. The active is the complex. Anything in the formulation that breaks the complex — strongly chelating co-actives, extreme pH, oxidising preservatives — effectively reduces the dose even if the label number is unchanged. This is the first place vehicle and active get conflated.
Serum, cream, solution: three different deliveries
The three most common topical formats are not interchangeable. Each changes a different variable.
- Aqueous solution. Plain GHK-Cu in buffered water, typically at pH around 7. This is the simplest format, the easiest to dose precisely, and the most common companion to microneedling because it can be applied immediately after channels open. Penetration into intact stratum corneum is modest; penetration after needling is much higher and is the reason the format exists in this niche.
- Serum. Water-based vehicle with humectants (glycerin, hyaluronic acid, propanediol), often a small fraction of penetration enhancer (a low-percentage glycol, occasionally a phospholipid). The serum format trades some active concentration for residence time on the skin and improved hydration of the stratum corneum, which raises the effective penetration of small peptides over a multi-hour window. Serums are the most common format for daily home use.
- Cream. Oil-in-water emulsion with emulsifiers, occlusive lipids, and usually several other actives layered in. The cream format raises occlusion, which can substantially increase peptide retention at the application site, but the formulation complexity also raises the chance of vehicle-active interaction. Creams are where most "stopped working after I switched products" reports actually come from, and the cause is rarely the GHK content.
pH is doing more than the label admits
The copper-tripeptide complex is most stable in the mildly acidic to near-neutral range, roughly pH 5 to 7. Below about pH 4.5 the complex starts to dissociate; above about pH 8 the copper begins to precipitate as hydroxide and the active is lost from solution. A serum formulated at pH 6 is in a comfortable window. A serum stacked under a vitamin C product at pH 3 is being partially dissociated at the contact zone. A cream that depends on a high-pH preservative system can quietly degrade the active over the shelf life. None of this is visible on the label, and almost all of it is attributed by users to "this batch is weaker." The batch is usually fine; the stack is the problem.
What changes the time-to-read
The subjective time course of a GHK-Cu protocol is heavily formulation-dependent, which is why pooling reviews across products almost never produces a clean answer. The aqueous-solution-after-needling route tends to show visible textural change within two to three weeks because the delivered dose per session is much higher than passive topical application. Daily serum use on intact skin tends to show change over six to twelve weeks because the per-session delivered dose is small and the change accumulates slowly. Cream-based daily use sits between the two, with the additional confounder that any other actives in the cream are contributing in parallel. Reading any of these on a two-week timeline against the wrong baseline is the most common reason a protocol gets abandoned for being "ineffective."
What to log to separate vehicle from molecule
The fields that turn this from "the new serum isn't doing anything" into a comparison:
- Format and concentration. Serum / cream / solution, and the labelled GHK-Cu percentage. Two different formats at the same percentage are not the same dose.
- Application protocol. Frequency, time of day, area applied, layered under or over which other products. The stack matters more than most users assume.
- pH context. If the routine includes acid actives (vitamin C, AHAs, BHAs), note their position in the order. Anything contacting the GHK layer at pH below 5 is degrading active.
- Skin baseline photos. Same lighting, same angle, same time of day, weekly. The improvement is gradual; the only honest comparator is the photo from four weeks ago.
- Other variables. Sleep, sun exposure, retinoid use, and seasonal humidity all move the same outcomes the formulation is being judged on. Annotated in the same log, they stop pretending to be GHK effects.
- Format switches. When changing from serum to cream or vice versa, log the switch as a discrete event. Most "stopped working" reports compress a format change and a slow-onset response into one impression.
What the data does not say
The peer-reviewed work on GHK-Cu in cosmetic concentrations is real but modest in scale, and the head-to-head comparisons of serum versus cream versus aqueous-after-needling at matched concentrations are essentially absent from the literature. The mechanistic story above is reasonably well grounded in the in vitro and ex vivo work; the magnitude of the effect at any given concentration in any given vehicle on any given skin is not well predicted by the available data. None of this is medical advice, and none of it justifies pushing the concentrations or the application frequency beyond the ranges the published work covers.
The practical summary
GHK-Cu serum, cream, and aqueous solution deliver the same active through three different vehicles, and the vehicles do enough work that the molecule cannot be read cleanly without controlling for the format. The complex is most stable at pH 5 to 7; the most common reason a routine reads as ineffective is a stack that drives the contact pH outside that window. The most common reason a switch reads as a downgrade is a format change folded into a slow-onset comparison. Logging format, concentration, stack order, and weekly baseline photos turns the comparison from impression into something readable.